Shares of Applied Therapeutics (NASDAQ: APLT) had skyrocketed 70.5% as of 10:43 a.m. ET on Wednesday. The huge gain came after the U.S. Food and Drug Administration (FDA) told the company that an Advisory Committee meeting to review the New Drug Application (NDA) for govorestat in treating galactosemia, ...
motleyfoolusx:aplt